INS and polycystic ovary syndrome: A single-arm, 12-week trial conducted in 14 women with PCOS also revealed that the KD is a feasible, non-pharmacological intervention to improve body weight, body composition, insulin-sensitivity, cardiometabolic risk, and female-specific circulating hormones [12].